Reports

Reports

• 2020
  • Annual Performance Report for the Prescription Drug Rebate Program (Rider 119) (Nov. 2020) (PDF)
  • Evaluation of Opioid Drug Prescribing Practices Under Medicaid (Sept. 2020) (PDF)
  • Evaluation of Strategies to Achieve Cost Savings for Medicaid Prescription Drugs (Sept. 2020) (PDF)
• 2019
  • Rider 60 Report Final Report on the Study of Potential Cost Savings in the Administration of Prescription Drug Benefits [Addendum 1 to Deliverable 2] (PDF) (Mar. 2019)
  • DUR Annual Report (Medicaid.gov)
• 2018
  • Evaluation of Pharmacy Service Delivery Models (Rider 23) (PDF) (Dec. 2018)
  • Prescription Drug Benefit Administration in Medicaid, CHIP, and Other Health-Related Services (Rider 60) (PDF) (Aug. 2018)
  • Annual Performance Report for the Prescription Drug Rebate Program (Rider 159) (PDF) (Aug. 2018)
  • DUR Annual Report (Medicaid.gov)
• 2017
  • Clear Process for Including Prescription Drugs on the Texas Drug Code Index (Rider 204) (Nov. 2017)
  • Annual Performance Report for the Prescription Drug Rebate Program (Rider 23) (Aug. 2017)
  • State of Texas Vendor Drug Program Formulary Control State vs. MCO (Jan. 2017)

HHS Quarterly Drug Use and Expenditure Patterns

The quarterly use and expenditure pattern reports provide prescription drug use and expenditure information for the most prescribed individual drugs and therapeutic drug classes.

Links

HHS Reports and Presentations

HHS Records and Statistics

DUR Annual Reports (Medicaid.gov)